Derm News: 2007.3(2)
Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications
Experimental Dermatology 16 (1), 28-36.
Douglas A. Plager, Alexey A. Leontovich, Susan A. Henke, Mark D.P. Davis, Marian T. McEvoy, Gabriel F. Sciallis II, Mark R. Pittelkow
Atopic dermatitis (AD) is a common pruritic dermatitis with macroscopically non-lesional skin that is often abnormal. Therefore, we used high-density oligonucleotide arrays to identify cutaneous gene transcription changes associated with early AD inflammation as potential disease control targets. Skin biopsy specimens analysed included normal skin from five healthy non-atopic adults and both minimally lesional skin and nearby or contralateral non-lesional skin from six adult AD patients.
Data were analysed on an individual gene basis and to identify biologically relevant gene networks. Transcription levels of selected genes were also analysed by quantitative PCR. Differential transcription occurring early in AD skin was indicated for (i) individual genes such as C-C chemokine ligand (CCL)18, CCL13, and interferon-a2 (IFNa2), (ii) genes associated with peroxisome proliferator-activated receptor (PPAR)a- and PPAR?-regulated transcription, and possibly for (iii) immunoglobulin J-chain and heavy chain isotype transcripts.
These data suggest that local changes in immunoglobulin-associated transcription may favour IgE over secretory immunoglobulin (multimeric IgM and IgA) expression in AD skin. Decreased PPAR activity appears common to both AD and psoriasis, and reduced cutaneous IFNa2 transcription also appears characteristic of AD. Identification of these genes and pathways will direct future research towards controlling AD.
Back to Current Volume:
Dermatology News 2007.3
The Derm News service provided by the Editorial Consultants of Skin Therapy Letter© and its founding editor Dr. Stuart Maddin.